Merck Riled In Tax Dispute With U.S. And Canada
Pharmaceutical giant Merck & Co. disclosed on Tuesday that in addition to other woes, liabilities from four tax disputes in North America could cost it a total of $5.58 billion....To view the full article, register now.
Already a subscriber? Click here to view full article